Search Results
Anti-Fibrotic Drug Development Summit
Therapies Under Investigation for PF: What's Coming Down the Pike | PFF Summit 2021
Drug Development in IPF: What is on the Horizon I Andy Limper, MD
Applying the Evidence on Antifibrotic Agents for IPF
Insilico Medicine's first AI-discovered antifibrotic drug goes first-in-human
AdAlta fibrosis briefing: Sam Cobb, CEO AdAlta Limited
[Webinar] MissionDMD: FibroGen’s Anti-Fibrosis Program - May 2016
Gene Therapy: The Power of Advocacy & Real World Evidence -- PPMD 2023 Annual Conference
Progressive Fibrotic ILD | Kevin Flaherty, MD, MS
Novel i-Body Therapeutics for Fibrotic Indications and Cancer: AdAlta Limited Presents at GCFF Jun10
In the Pipeline: Combating Fibrosis - Day 4 - PPMD Annual 2020
PFF Summit 2021: Pulmonary Fibrosis 101 and Introduction to the Pulmonary Fibrosis Foundation